301130SZSE

Articles of Association of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.

✨ AI Summary

The Articles of Association outlines the governance structure and operational guidelines for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd. It establishes the company's legal framework, including shareholder rights, board responsibilities, and financial management. Key figures include the registered capital of RMB 76.494685 million and the issuance of 20.200986 million shares. The document serves as a binding legal framework for the company and its stakeholders.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Chapter 1 General Principles

Article 1

To protect the legitimate rights and interests of the company, shareholders, employees, and creditors, and to regulate the organization and behavior of the company, these Articles are formulated in accordance with the Company Law of the People's Republic of China (hereinafter referred to as the "Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as the "Securities Law"), the Guidelines for Articles of Association of Listed Companies, and other relevant regulations.

Article 2

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd. (hereinafter referred to as the "Company") is a joint-stock limited company established in accordance with the Company Law and other relevant regulations. The Company was approved by the Jilin Provincial People's Government with document [2001] No. 74, merging the original limited liability company Tianhua Pharmaceutical with Jilin Province Xidian Pharmaceutical Co., Ltd. and established as a joint-stock company; it is registered with the Jilin City Market Supervision Administration and has obtained a business license with a unified social credit code of 912202011239483018.

Article 3

The Company was registered on January 4, 2022, with the approval of the China Securities Regulatory Commission (hereinafter referred to as "CSRC"), and issued 20,200,986 shares of ordinary shares to the public for the first time. It was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange on February 23, 2022.

Article 4

The registered name of the Company is: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd. The English name of the Company is: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.

Article 5

The Company's address is: No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Postal Code: 132300.

Article 6

The registered capital of the Company is RMB 76,494,685.

Article 7

The Company is a joint-stock limited company with perpetual existence.

Article 8

The chairman of the board serves as the legal representative of the Company. If the legal representative resigns, it is deemed that they have simultaneously resigned from their position as legal representative. If the legal representative resigns, the Company shall determine a new legal representative within thirty days from the date of resignation.

Article 9

The legal representative shall bear the legal consequences of civil activities conducted in the name of the Company. Any restrictions on the powers of the legal representative set forth in these Articles or by the shareholders' meeting shall not be asserted against bona fide third parties. If the legal representative causes damage to others while performing their duties, the Company shall bear civil liability. After the Company bears civil liability, it may seek compensation from the legal representative who is at fault in accordance with the law or these Articles.

Article 10

Shareholders shall be liable to the Company only to the extent of their subscribed shares, and the Company shall be liable for its debts with all its assets.

Article 11

These Articles shall take effect from the date of their promulgation and shall serve as a legally binding document regulating the organization and behavior of the Company, as well as the rights and obligations between the Company and its shareholders, and among shareholders. According to these Articles, shareholders may sue each other, shareholders may sue the Company's directors and senior management, and the Company may sue shareholders, directors, and senior management.

Article 12

The term "senior management" as used in these Articles refers to the Company's manager, deputy managers, financial officer, board secretary, and other personnel as stipulated in these Articles.

Article 13

The Company shall establish a Communist Party organization and carry out Party activities in accordance with the Constitution of the Communist Party of China. The Company shall provide necessary conditions for the activities of the Party organization.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.